当前位置:首页 - 行情中心 - 丰原药业(000153) - 财务分析 - 现金流量表

丰原药业

(000153)

  

流通市值:28.45亿  总市值:28.81亿
流通股本:4.59亿   总股本:4.65亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金874,594,192.563,822,104,543.712,477,831,768.621,601,266,628.71
  收到的税费返还7,682,597.3519,314,096.913,542,584.152,414,216.28
  收到其他与经营活动有关的现金29,673,107.22211,266,293.0266,044,948.638,986,235.91
  经营活动现金流入小计911,949,897.134,052,684,933.642,547,419,301.371,642,667,080.9
  购买商品、接受劳务支付的现金673,812,355.422,713,306,793.061,713,106,954.991,101,849,947.52
  支付给职工以及为职工支付的现金112,091,578.35396,934,323.05309,789,737.35210,708,151.68
  支付的各项税费42,285,955.87196,031,860.5149,514,812.42104,726,728.17
  支付其他与经营活动有关的现金74,459,110.42627,114,194.41286,194,244.81197,239,363.61
  经营活动现金流出小计902,649,000.063,933,387,171.022,458,605,749.571,614,524,190.98
  经营活动产生的现金流量净额9,300,897.07119,297,762.6288,813,551.828,142,889.92
二、投资活动产生的现金流量:
  收回投资收到的现金-1,400,0001,400,0001,400,000
  取得投资收益收到的现金-8,557,138.88,477,122.5-
  处置固定资产、无形资产和其他长期资产收回的现金净额670406,922.71131,262.7529,772.75
  投资活动现金流入小计67010,364,061.5110,008,385.251,429,772.75
  购建固定资产、无形资产和其他长期资产支付的现金30,116,799.8220,605,804.57165,372,565.71133,351,252.93
  投资支付的现金-60,000,000--
  投资活动现金流出小计30,116,799.8280,605,804.57165,372,565.71133,351,252.93
  投资活动产生的现金流量净额-30,116,129.8-270,241,743.06-155,364,180.46-131,921,480.18
三、筹资活动产生的现金流量:
  取得借款收到的现金390,746,994.031,534,129,075.21967,314,958.53656,357,601.84
  收到其他与筹资活动有关的现金130,000,000---
  筹资活动现金流入小计520,746,994.031,534,129,075.21967,314,958.53656,357,601.84
  偿还债务支付的现金274,325,545.511,234,242,029.58791,242,029.58513,894,188
  分配股利、利润或偿付利息支付的现金7,080,955.581,164,155.7770,053,675.560,853,537.08
  支付其他与筹资活动有关的现金5,075,610.68155,604,116.3320,227,814.613,423,842.42
  筹资活动现金流出小计286,482,111.691,471,010,301.68881,523,519.68588,171,567.5
  筹资活动产生的现金流量净额234,264,882.3463,118,773.5385,791,438.8568,186,034.34
四、汇率变动对现金及现金等价物的影响-15,647.61-17,174.26-8,113.59-2,953.17
五、现金及现金等价物净增加额213,434,002-87,842,381.1719,232,696.6-35,595,509.09
  加:期初现金及现金等价物余额128,469,642.69216,312,023.86216,312,023.86216,312,023.86
  期末现金及现金等价物余额341,903,644.69128,469,642.69235,544,720.46180,716,514.77
补充资料:
  净利润-94,804,169.89-75,002,400.41
  资产减值准备-33,415,538.92-6,096,773.37
  固定资产和投资性房地产折旧-104,433,142.53-52,104,741.5
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-104,433,142.53-52,104,741.5
  无形资产摊销-16,895,821.21-7,823,891.96
  长期待摊费用摊销-14,592,506.24-7,407,372.43
  处置固定资产、无形资产和其他长期资产的损失-326,419.46--
  固定资产报废损失-172,125.98-59,287.73
  公允价值变动损失-2,650,611.03-710,807.5
  财务费用-34,898,880.81-15,874,108.64
  投资损失--8,556,538.8-600
  递延所得税--6,454,122.22--2,069,409.76
  其中:递延所得税资产减少--5,839,575.75--2,274,207.45
    递延所得税负债增加--614,546.47-204,797.69
  存货的减少-46,048,966.86-34,721,375.65
  经营性应收项目的减少--52,619,409.65--154,789,138.12
  经营性应付项目的增加--188,351,063.69--26,763,941.47
  其他----1,753,112.03
  现金的期末余额-128,469,642.69-180,716,514.77
  减:现金的期初余额-216,312,023.86-216,312,023.86
  现金及现金等价物的净增加额--87,842,381.17--35,595,509.09
公告日期2026-04-292026-04-292025-10-242025-08-22
审计意见(境内)标准无保留意见
TOP↑